Name: Latest research reports of Divi's Laboratories Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 4
Author: ICICI Securities Limited

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star

6538.0000 -14.00 (-0.21%)

NSE May 22, 2025 15:31 PM

New 52W High in past week

Volume: 327.0K

Divi's Laboratories Ltd.

16 Aug 2022

6538.00

-0.21%

Recovery in API; margins hit

Accumulate: Divi's Laboratories Ltd.

Target

ICICI Securities Limited

Divi’s Laboratories’ (Divi’s) Q1FY23 performance was a mixed bag with revenue ahead of our estimates while margin was lower.

Divi's Laboratories Ltd. has gained 62.78% in the last 1 Year